Last reviewed · How we verify
TAU
Tau protein aggregation inhibitor.
Tau protein aggregation inhibitor. Used for Alzheimer's disease.
At a glance
| Generic name | TAU |
|---|---|
| Also known as | Treatment as Usual, Usual care, Treatment As Usual |
| Sponsor | Montefiore Medical Center |
| Drug class | Tau protein aggregation inhibitor |
| Target | Tau protein |
| Modality | Small molecule |
| Therapeutic area | Neurology |
| Phase | FDA-approved |
Mechanism of action
Tau protein aggregation is a hallmark of neurodegenerative diseases such as Alzheimer's disease. TAU inhibits this aggregation, potentially slowing disease progression.
Approved indications
- Alzheimer's disease
Common side effects
- Headache
- Dizziness
- Nausea
- Vomiting
- Fatigue
- Diarrhea
- Muscle spasms
- Insomnia
- Depression
- Anxiety
Key clinical trials
- A Brief Case Management Intervention to Promote Personal Recovery and Prevent Psychiatric Involuntary Readmissions: a Randomised Controlled Trial (NA)
- The Effects of Mindfulness-based Cognitive Therapy in People With Parkinson's Disease (NA)
- The Trans-Led Care Study (NA)
- Integrated Outpatient Treatment of Opioid Use Disorder and Severe Injection Related Infections (PHASE2)
- A Study to Evaluate the Efficacy of NIO752 in Participants With Progressive Supranuclear Palsy (PHASE3)
- The STEP-MIED Trial: Digital Stepped-Care for Emotional Disorders (NA)
- Alzheimer's Disease Neuroimaging Initiative 4
- A Phase Ia/Ib, First-in-human (FIH) Study for Safety, Tolerability, Pharmacokinetics (PK), and Clinical Activity Evaluation of ADEL-Y01 (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- TAU CI brief — competitive landscape report
- TAU updates RSS · CI watch RSS
- Montefiore Medical Center portfolio CI